De WaardA-KMWåndellPEHolzmannMJet al.Barriers and facilitators to participation in a health check for cardiometabolic diseases in primary care: a systematic review. Eur J Prev Cardiol2018; 25: 1326–1340.
2.
EliassonMErikssonMLundqvistRet al.Comparison of trends in cardiovascular risk factors between two regions with and without a community and primary care prevention programme. Eur J Prev Cardiol2018; 25: 1765–1772.
ChernomordikFSabbagATzurBet al.Cardiac rehabilitation following an acute coronary syndrome: trends in referral, predictors and mortality outcome in a multicenter national registry between years 2006–2013: report from the Working Group on Cardiac Rehabilitation, the Israeli Heart Society. Eur J Prev Cardiol2017; 24: 123–132.
5.
DuLChengZZhangYet al.The impact of medication adherence on clinical outcomes of coronary artery disease: a meta-analysis. Eur J Prev Cardiol2017; 24: 962–970.
6.
Toth-ZsámbokiEHorváthZHajtmanLet al.Cardiac rehabilitation programme as a non-pharmacological platelet inhibitory tool in acute coronary syndrome survivors. Eur J Prev Cardiol2017; 24: 1148–1156.
7.
ZellerTSchnabelRBAppelbaumSet al.Low testosterone levels are predictive for incident atrial fibrillation and ischaemic stroke in men, but protective in women – results from the FINRISK study. Eur J Prev Cardiol2018; 25: 1133–1139.
8.
Cea SorianoLFowkesFGRJohanssonSet al.Cardiovascular outcomes for patients with symptomatic peripheral artery disease: a cohort study in The Health Improvement Network (THIN) in the UK. Eur J Prev Cardiol2017; 24: 1927–1937.
9.
BavieraMBerteleVAvanziniFet al.Peripheral arterial disease: changes in clinical outcomes and therapeutic strategies in two cohorts, from 2002 to 2008 and from 2008 to 2014. A population-based study. Eur J Prev Cardiol2018; 25: 1735–1743.
10.
FrederixISolmiFPiepoliMFet al.Cardiac telerehabilitation: a novel cost-efficient care delivery strategy that can induce long-term health benefits. Eur J Prev Cardiol2017; 24: 1708–1717.
11.
DuLChengZZhangYet al.The impact of medication adherence on clinical outcomes of coronary artery disease: a meta-analysis. Eur J Prev Cardiol2017; 24: 962–970.
12.
KoenigW. Inflammation revisited: atherosclerosis in the post-CANTOS era. Eur Cardiol2017; 12: 89–91.
13.
MunkhaugenJOtterstadJEDammenTet al.The prevalence and predictors of elevated C-reactive protein after a coronary heart disease event. Eur J Prev Cardiol2018; 25: 923–931.
